Document is current
Any future updates will be listed below
-
Authors
Christiaens, Laura https://orcid.org/0009-0009-8190-416X
Raat, Willem https://orcid.org/0000-0002-9591-3974
Meel, Liesbeth https://orcid.org/0009-0007-1831-5624
Avonts, Marijke https://orcid.org/0000-0001-5419-7855
Van de Putte, Marie https://orcid.org/0009-0005-2381-2735
Vaes, Bert https://orcid.org/0000-0001-5244-1930
Van den Bulck, Steve https://orcid.org/0000-0003-0744-3923
-
Funding
Funding for this research was provided by:
Novartis Pharma NV
- License Information
-
More Information
Article History
Received: 23 June 2025
Accepted: 21 October 2025
First Online: 29 November 2025
Declarations
:
: This study, conducted in accordance with the ICH GCP guidelines, received approval from the Social and Societal Ethics Committee: G-2024-8020. This study was conducted in accordance with the ethical principles of the Declaration of Helsinki, as approved by the World Medical Association. Prior to the study, all participants received an Informed Consent Form outlining the research details. Panel members provided written informed consent to participate in the study. Participants were assured that no potentially identifying details would be reported, all data would be kept confidential, and they could withdraw at any time or decline to answer any question without any negative consequences. No electronic health record data were accessed or reviewed during the development of the quality indicators.
: Not applicable.
: The authors declare no competing interests.
